Stonegate Capital Partners has updated its coverage of NU Skin Enterprises Inc. following the company’s fourth-quarter financial results. NU Skin reported revenue of $370.3 million, adjusted net income of $14.5 million, and adjusted earnings per share of $0.29 for the period. These figures came in slightly below Stonegate’s estimates of $380.2 million in revenue, $15.1 million in adjusted net income, and $0.30 in adjusted EPS, but management noted the results were at the low end of revenue guidance and the high end of EPS guidance.
The company’s Rhyz segment contributed $48.52 million in revenue, with $42.45 million coming from manufacturing and $6.07 million from other Rhyz operations. Meanwhile, the core Nu Skin business maintained a gross margin of 77.6% and benefited from disciplined spending as selling expenses declined to 40.8% of the core business. Management highlighted several factors contributing to the earnings results, including strategic penetration into India and other emerging markets, overall margin expansion, and a one-time tax benefit during fiscal year 2025.
Despite revenue coming in weaker than expected, NU Skin’s leadership emphasized continued focus on executing strategic initiatives. The company is advancing the rollout of its Prism iO platform in the first half of 2026 and has an India pre-launch underway with full market opening expected in the second half of 2026. For the full fiscal year 2026, management provided EPS guidance with a midpoint of $1.00, signaling confidence in the company’s strategic direction despite current revenue challenges.
The update from Stonegate Capital Partners provides investors with analysis of NU Skin’s performance and strategic positioning. The firm noted that while top-line results were below expectations, the company’s margin discipline and international expansion efforts, particularly in emerging markets like India, represent important growth drivers. The full research announcement, including downloadable images and additional details, is available through Stonegate’s reporting platform. Investors can access the complete analysis to view the full announcement for more comprehensive coverage of NU Skin’s financial position and strategic outlook.
This news story relied on content distributed by Reportable. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Following Q4 Results.